Cargando…

Development of a Mimotope Vaccine Targeting the Staphylococcus aureus Quorum Sensing Pathway

A major hurdle in vaccine development is the difficulty in identifying relevant target epitopes and then presenting them to the immune system in a context that mimics their native conformation. We have engineered novel virus-like-particle (VLP) technology that is able to display complex libraries of...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Rourke, John P., Daly, Seth M., Triplett, Kathleen D., Peabody, David, Chackerian, Bryce, Hall, Pamela R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224382/
https://www.ncbi.nlm.nih.gov/pubmed/25379726
http://dx.doi.org/10.1371/journal.pone.0111198
_version_ 1782343336632254464
author O’Rourke, John P.
Daly, Seth M.
Triplett, Kathleen D.
Peabody, David
Chackerian, Bryce
Hall, Pamela R.
author_facet O’Rourke, John P.
Daly, Seth M.
Triplett, Kathleen D.
Peabody, David
Chackerian, Bryce
Hall, Pamela R.
author_sort O’Rourke, John P.
collection PubMed
description A major hurdle in vaccine development is the difficulty in identifying relevant target epitopes and then presenting them to the immune system in a context that mimics their native conformation. We have engineered novel virus-like-particle (VLP) technology that is able to display complex libraries of random peptide sequences on a surface-exposed loop in the coat protein without disruption of protein folding or VLP assembly. This technology allows us to use the same VLP particle for both affinity selection and immunization, integrating the power of epitope discovery and epitope mimicry of traditional phage display with the high immunogenicity of VLPs. Previously, we showed that using affinity selection with our VLP platform identifies linear epitopes of monoclonal antibodies and subsequent immunization generates the proper antibody response. To test if our technology could identify immunologic mimotopes, we used affinity selection on a monoclonal antibody (AP4-24H11) that recognizes the Staphylococcus aureus autoinducing peptide 4 (AIP4). AIP4 is a secreted eight amino acid, cyclized peptide produced from the S. aureus accessory gene regulator (agrIV) quorum-sensing operon. The agr system coordinates density dependent changes in gene expression, leading to the upregulation of a host of virulence factors, and passive transfer of AP4-24H11 protects against S. aureus agrIV-dependent pathogenicity. In this report, we identified a set of peptides displayed on VLPs that bound with high specificity to AP4-24H11. Importantly, similar to passive transfer with AP4-24H11, immunization with a subset of these VLPs protected against pathogenicity in a mouse model of S. aureus dermonecrosis. These data are proof of principle that by performing affinity selection on neutralizing antibodies, our VLP technology can identify peptide mimics of non-linear epitopes and that these mimotope based VLP vaccines provide protection against pathogens in relevant animal models.
format Online
Article
Text
id pubmed-4224382
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-42243822014-11-18 Development of a Mimotope Vaccine Targeting the Staphylococcus aureus Quorum Sensing Pathway O’Rourke, John P. Daly, Seth M. Triplett, Kathleen D. Peabody, David Chackerian, Bryce Hall, Pamela R. PLoS One Research Article A major hurdle in vaccine development is the difficulty in identifying relevant target epitopes and then presenting them to the immune system in a context that mimics their native conformation. We have engineered novel virus-like-particle (VLP) technology that is able to display complex libraries of random peptide sequences on a surface-exposed loop in the coat protein without disruption of protein folding or VLP assembly. This technology allows us to use the same VLP particle for both affinity selection and immunization, integrating the power of epitope discovery and epitope mimicry of traditional phage display with the high immunogenicity of VLPs. Previously, we showed that using affinity selection with our VLP platform identifies linear epitopes of monoclonal antibodies and subsequent immunization generates the proper antibody response. To test if our technology could identify immunologic mimotopes, we used affinity selection on a monoclonal antibody (AP4-24H11) that recognizes the Staphylococcus aureus autoinducing peptide 4 (AIP4). AIP4 is a secreted eight amino acid, cyclized peptide produced from the S. aureus accessory gene regulator (agrIV) quorum-sensing operon. The agr system coordinates density dependent changes in gene expression, leading to the upregulation of a host of virulence factors, and passive transfer of AP4-24H11 protects against S. aureus agrIV-dependent pathogenicity. In this report, we identified a set of peptides displayed on VLPs that bound with high specificity to AP4-24H11. Importantly, similar to passive transfer with AP4-24H11, immunization with a subset of these VLPs protected against pathogenicity in a mouse model of S. aureus dermonecrosis. These data are proof of principle that by performing affinity selection on neutralizing antibodies, our VLP technology can identify peptide mimics of non-linear epitopes and that these mimotope based VLP vaccines provide protection against pathogens in relevant animal models. Public Library of Science 2014-11-07 /pmc/articles/PMC4224382/ /pubmed/25379726 http://dx.doi.org/10.1371/journal.pone.0111198 Text en © 2014 O’Rourke et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
O’Rourke, John P.
Daly, Seth M.
Triplett, Kathleen D.
Peabody, David
Chackerian, Bryce
Hall, Pamela R.
Development of a Mimotope Vaccine Targeting the Staphylococcus aureus Quorum Sensing Pathway
title Development of a Mimotope Vaccine Targeting the Staphylococcus aureus Quorum Sensing Pathway
title_full Development of a Mimotope Vaccine Targeting the Staphylococcus aureus Quorum Sensing Pathway
title_fullStr Development of a Mimotope Vaccine Targeting the Staphylococcus aureus Quorum Sensing Pathway
title_full_unstemmed Development of a Mimotope Vaccine Targeting the Staphylococcus aureus Quorum Sensing Pathway
title_short Development of a Mimotope Vaccine Targeting the Staphylococcus aureus Quorum Sensing Pathway
title_sort development of a mimotope vaccine targeting the staphylococcus aureus quorum sensing pathway
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224382/
https://www.ncbi.nlm.nih.gov/pubmed/25379726
http://dx.doi.org/10.1371/journal.pone.0111198
work_keys_str_mv AT orourkejohnp developmentofamimotopevaccinetargetingthestaphylococcusaureusquorumsensingpathway
AT dalysethm developmentofamimotopevaccinetargetingthestaphylococcusaureusquorumsensingpathway
AT triplettkathleend developmentofamimotopevaccinetargetingthestaphylococcusaureusquorumsensingpathway
AT peabodydavid developmentofamimotopevaccinetargetingthestaphylococcusaureusquorumsensingpathway
AT chackerianbryce developmentofamimotopevaccinetargetingthestaphylococcusaureusquorumsensingpathway
AT hallpamelar developmentofamimotopevaccinetargetingthestaphylococcusaureusquorumsensingpathway